| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/18/2009 | CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides |
| 03/18/2009 | CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/18/2009 | CN100469783C Oligose ,sulfating product and oligose cluster and its uses |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/18/2009 | CN100469773C Preparation method and usage for nitrogen-containing flavone derivatives |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CN100469371C Manufacturing technique for gingko leaf extracts |
| 03/18/2009 | CN100469363C Therapeutic combinations of fatty acids |
| 03/18/2009 | CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/18/2009 | CN100469253C Method for preparing tumor mutation-resisting yoghourt with micron ash tree pollen, pine pollen, bee pollen and ganoderma lucidum spore powder |
| 03/17/2009 | US7504507 carboxamide linked compounds based on benzo[b][1,6]naphthyridin-1 (2H)-one, which differ from previous acridine based compounds by the incorporation of a lactam or thiolactam function in one of the outer rings |
| 03/17/2009 | US7504482 Recombinant soluble Fc receptors |
| 03/17/2009 | US7504479 Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504416 4-substituted quinolines as antitumor agents |
| 03/17/2009 | US7504414 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504410 such as N-[3-[[5-bromo-4-[[3-[[[1-(trifluoromethyl)cyclobutyl]carbonyl]amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide; Chks (checkpoint kinases), Akts (protein kinases B) and Pdks (phosphoinositide-dependent kinases) inhibitors; antiproliferative agents |
| 03/17/2009 | US7504408 Quinzoline derivatives for use in the treatment of cancer |
| 03/17/2009 | US7504405 Mitotic kinesin inhibitors |
| 03/17/2009 | US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation |
| 03/17/2009 | US7504247 2-O sulfatase compositions and methods of degradation therewith |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | US7504115 Shark cartilage extracts and use thereof for immunomodulation |
| 03/17/2009 | US7504104 Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens |
| 03/17/2009 | US7504102 Therapeutic mixture comprising immunoglobulin specific to vitronectin receptor for use in diagnosis, prevention and treatment of restenosis |
| 03/17/2009 | US7504100 Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow |
| 03/17/2009 | CA2639658A1 Design and synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/17/2009 | CA2360668C The use of 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 03/17/2009 | CA2338638C Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity |
| 03/17/2009 | CA2330025C Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/12/2009 | WO2009033140A1 Microrna signatures in human ovarian cancer |
| 03/12/2009 | WO2009033084A1 Pyrazolo-pyridines as tyrosine kinase inhibitors |
| 03/12/2009 | WO2009032930A2 Compositions comprising human integrin-linked kinase-sirna and methods of use thereof |
| 03/12/2009 | WO2009032703A1 2- (het) arylamino-6-aminopyridine derivatives and fused forms thereof as anaplastic lymphoma kinase inhibitors |
| 03/12/2009 | WO2009032668A2 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 03/12/2009 | WO2009032667A1 Thiazole and oxazole kinase inhibitors |
| 03/12/2009 | WO2009032364A1 Activation of nuclear factor-kappa b |
| 03/12/2009 | WO2009031999A1 Fr901464 and analogs with antitumor activity and method for their preparation |
| 03/12/2009 | WO2009031876A1 Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer |
| 03/12/2009 | WO2009031709A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031708A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031706A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN |
| 03/12/2009 | WO2009031671A1 Method for promoting the expression of p53, and p53 expression promoter for use in the method |
| 03/12/2009 | WO2009031230A1 Anti-cd20 monoclonal antibodies |
| 03/12/2009 | WO2009031195A1 Composition containing flavanone compound monomer |
| 03/12/2009 | WO2009031151A2 Antibodies and methods for diagnosing and treating cancer |
| 03/12/2009 | WO2009030998A1 Pyrimidine compounds as toll-like receptor (tlr) agonists |
| 03/12/2009 | WO2009030996A1 Triazole compounds as toll-like receptor (tlr) agonists |
| 03/12/2009 | WO2009030952A2 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway |
| 03/12/2009 | WO2009030890A1 Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma |
| 03/12/2009 | WO2009030871A1 Pyrrolopyrimidine derivatives having hsp90 inhibitory activity |
| 03/12/2009 | WO2009030734A1 Intraoperative trifunctional antibody administration for prophylaxis of intraperitoneal tumor cell dissemination |
| 03/12/2009 | WO2009030368A1 Combination therapy with type i and type ii anti-cd20 antibodies |
| 03/12/2009 | WO2009030333A1 Thiadiazinone derivatives |
| 03/12/2009 | WO2009030316A1 1,3-dihydroisoindole derivatives |
| 03/12/2009 | WO2009030103A1 The uses of salmonella typhi or salmonella paratyphi for preparation of medicaments for combating tumors |
| 03/12/2009 | WO2009030094A1 Function and use of new lysosome-associated apoptosis-inducing protein containing ph and fyve domains (lapf) |
| 03/12/2009 | WO2009030092A1 Culture medium and method for in vitro culturing human adult primary mesenchymal stem cells on a large scale, primary mesenchymal stem cells obtained by the method, the uses thereof |
| 03/12/2009 | WO2009030088A1 Function and use of a new human calcium/calmodulin-dependent protein kinase ii inhibitor |
| 03/12/2009 | WO2009030086A1 Functions and uses of human bone marrow stromal cell-derived growth inhibitor |
| 03/12/2009 | WO2009030084A1 NEW FUNCTIONS AND USES OF HUMAN ONCOGENE-LIKE SMALL G PROTEIN RabJ |
| 03/12/2009 | WO2009030073A1 A dTDP-β-D-FUCOFURANOSE, ITS PREPARATION METHOD AND USE |
| 03/12/2009 | WO2009030066A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof |
| 03/12/2009 | WO2009030065A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 03/12/2009 | WO2009029998A1 Retrometabolic compounds |
| 03/12/2009 | WO2009011617A3 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS |
| 03/12/2009 | WO2009010139A3 Quinazolinamide derivatives |
| 03/12/2009 | WO2008149244A3 Compositions and methods comprising analogues of radicicol a |
| 03/12/2009 | WO2008146167A3 Improved methods of using phosphoantigens together with interleukin-2 for the treatment of cancer |
| 03/12/2009 | WO2008136850A3 Cobalamin conjugates useful as imaging and therapeutic agents |
| 03/12/2009 | WO2008136018A3 4beta-amin0 podophyllotoxin congeners as potential anticancer agents and a process for the preparation thereof |
| 03/12/2009 | WO2008113557A3 Anti-infective agents |
| 03/12/2009 | WO2008110624A9 Sirna-mediated silencing of genes for treating chemotherapeutic drug-resistant epithelial tumors |
| 03/12/2009 | WO2008109498A3 Nucleic acid compounds for inhibiting hdac gene expression and uses thereof |
| 03/12/2009 | WO2008079849A3 Antibodies to insulin-like growth factor receptor |
| 03/12/2009 | WO2008059052A9 Improved methods of using phosphoantigen for the treatment of cancer |
| 03/12/2009 | WO2008040362A3 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| 03/12/2009 | WO2008021389A8 Using pi3k and mek modulators in treatments of cancer |
| 03/12/2009 | WO2008014219A8 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 03/12/2009 | WO2008013807A9 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 03/12/2009 | WO2006122806A3 1,3-dihydro-imidazo [4,5-c] quinolin-2-ones as lipid kinase inhibitors |
| 03/12/2009 | US20090069564 Methods and Compositions for Selectin Inhibition |
| 03/12/2009 | US20090069441 Motuporamine Mimic Agents |
| 03/12/2009 | US20090069434 Cystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 03/12/2009 | US20090069432 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 03/12/2009 | US20090069424 TGF-alpha expression inhibitors |
| 03/12/2009 | US20090069420 Small molecule inhibitors of STAT3 with anti-tumor activity |
| 03/12/2009 | US20090069417 Carotenoid oxidation products as chemopreventive and chemotherapeutic agents |
| 03/12/2009 | US20090069410 Deuterium-enriched paclitaxel |
| 03/12/2009 | US20090069409 Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions |
| 03/12/2009 | US20090069402 Deuterium-enriched atrasentan |
| 03/12/2009 | US20090069396 Polyene Oxazoles and Processes for Their Preparation |
| 03/12/2009 | US20090069394 Cancer treatment with epothilones |
| 03/12/2009 | US20090069393 Parenteral formulation for epothilone analogs |
| 03/12/2009 | US20090069391 such as N-hydroxy-6-{1-[(4-methoxybenzyl)amino]-2-[(4-methoxyphenyl)amino]-2-oxoethyl}-1-benzothiophene-2-carboxamide, used to treat cancer, tumors, neurodegenerative, autoimmune, allergic and inflammatory diseases, and as histone deacetylase inhibitors |